Korro Bio, Inc. (1KKR)
MTA
80.64
+1.02 (+1.28%)
Real-time Data
07:00 AM
Day's Range
80.6481.54
52 wk Range
72.02121.88
Financial Statements - 1KKR - Korro Bio, Inc.
Revenue
19.20B▲ 4.7%
Net Income
6.14B▲ 47.8%Net Margin 32.0%
EBITDA
4.20B▼ 12.9%
Free Cash Flow
316.99M▼ 94.3%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 19.20B | 18.33B |
| Cost of Goods | 15.75B | 15.08B |
| Gross Profit | 3.45B | 3.25B |
 Operating Expense | - | - |
| Operating Income | 490.19M | 784.86M |
| Non-Operating Interest | - | - |
| Other Income Expense | 6.49B | 4.05B |
| Pre Tax Income | 7.09B | 4.96B |
| Income Tax | 953.74M | 808.76M |
| Net Income | 6.14B | 4.15B |
| EPS Basic | 2.51 | 3.47 |
| EPS Diluted | 2.34 | 3.28 |
| Basic Shares Outstanding | 890.34M | 751.67M |
| Diluted Shares Outstanding | 890.34M | 751.67M |
| Ebit | 10.17B | 7.76B |
| Ebitda | 4.20B | 4.82B |
| Net Income Continuous Operations | 6.14B | 4.15B |
| Minority Interests | -3.77B | -1.82B |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
